CVE-2023-31923 Privilege escalation in n/a
An authenticated user with low privileges can escalate to full administrator access due to missing server-side validation in the web application.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2023-31923?
CVE-2023-31923 is a high-severity vulnerability in n/a, published on 22 May 2023. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.
Weakness: CWE-281
Which versions are affected by CVE-2023-31923?
It affects 1 product.
Products include Supremainc Biostar 2.
How do I fix CVE-2023-31923?
No fix has been published for CVE-2023-31923 yet. Limit exposure of the affected software until one is available.
Is CVE-2023-31923 being exploited?
It is not confirmed as exploited in the wild, but public exploit code for CVE-2023-31923 exists.
Other vulnerabilities in n/a
Sources
Also known as GHSA-q32m-5wqx-f57m.